Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term Debt
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Receivables: 2020-2025

Historic Receivables for Mainz Biomed N.V (MYNZ) over the last 1 years, with Jun 2025 value amounting to $1.2 million.

  • Mainz Biomed N.V's Receivables rose 245.07% to $1.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.8 million, marking a year-over-year increase of 133.76%. This contributed to the annual value of $50,815 for FY2024, which is 58.26% down from last year.
  • As of Q2 2025, Mainz Biomed N.V's Receivables stood at $1.2 million, which was up 2,356.11% from $50,815 recorded in Q4 2024.
  • Mainz Biomed N.V's 5-year Receivables high stood at $1.2 million for Q2 2025, and its period low was $50,815 during Q4 2024.
  • Over the past 3 years, Mainz Biomed N.V's median Receivables value was $145,681 (recorded in 2023), while the average stood at $320,186.
  • In the last 5 years, Mainz Biomed N.V's Receivables skyrocketed by 344.37% in 2021 and then crashed by 61.40% in 2023.
  • Quarterly analysis of 5 years shows Mainz Biomed N.V's Receivables stood at $196,592 in 2021, then reached $377,365 in 2022, then tumbled by 61.40% to $121,735 in 2023, then plummeted by 58.26% to $50,815 in 2024, then surged by 245.07% to $1.2 million in 2025.
  • Its Receivables stands at $1.2 million for Q2 2025, versus $50,815 for Q4 2024 and $361,688 for Q2 2024.